Rational Use of Haemophilus influenzae Type b Vaccine??? (Q40491611)

From Wikidata

Revision as of 08:22, 25 August 2024 by Cewbot (talk | contribs) (‎Removed claim: author name string (P2093): Harry Campbell, Modify PubMed ID: 7693429 citation data from NCBI, Europe PMC and CrossRef)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on September 1, 1993

Language	Label	Description	Also known as
English	Rational Use of Haemophilus influenzae Type b Vaccine???	scientific article published on September 1, 1993

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

Rational use of Haemophilus influenzae type b vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rational Use of Haemophilus influenzae Type b Vaccine??? (English)

1 reference

10.2165/00003495-199346030-00004

https://api.crossref.org/works/10.2165/00003495-199346030-00004

25 August 2024

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

1

object named as

Harry Campbell

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7693429

25 August 2024

author name string

Harden Carter

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7693429

25 August 2024

publication date

1 September 1993

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

378-383

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody persistence after accelerated immunisation against Haemophilus influenzae type b

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology and prevention of disease caused by Haemophilus influenzae type b.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7693429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199346030-00004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40491611&oldid=2235564153"